Patient‐derived forebrain cortical organoids reveal biphasic tau–MAP6–microtubule axis dysfunction in tauopathy
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Xiaohuan Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: tau Proteins, Tauopathies, Organoids, Microtubules. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Lisa Dean Moseley Foundation, NINDS NIH HHS, U.S. Department of Defense.
Abstract (Originalsprache)
INTRODUCTION In frontotemporal dementia (FTD), tau detaches from axonal microtubules and forms pathological aggregates. Rather than stabilizing microtubules, tau promotes labile microtubule domains, redefining its role in neurodegeneration and underscoring the need for human models that capture temporal disease progression. METHODS Human induced pluripotent stem cells carrying MAPT WT/P301L , MAPT WT/P301S , or MAPT WT/R406W mutations and isogenic controls were differentiated into forebrain cortical organoids (1 to 8 months). Tau isoforms, microtubule dynamics, MAP6 regulation, neuronal activity, tau mRNA stability, and tau pathology were analyzed using biochemical, imaging, and electrophysiological approaches, some of which were benchmarked to postmortem behavorial variant FTD cortex. RESULTS Early‐phase tau mutant organoids showed elevated tau, hyperdynamic microtubules, and neuronal hyperexcitability, partially reversible by tau reduction. Late‐phase organoids exhibited insoluble tau accumulation, microtubule hyperstability, and neurodegeneration and reactive astrocytes, accompanied by opposing, phase‐dependent MAP6 changes. DISCUSSION This work reveals a biphasic tau‐MAP6‐microtubule mechanism driving tauopathy and establishes these organoids as a platform for phase‐specific therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Translational Neuroscience, Michigan State University, Michigan, USA.
- Department of Psychiatry and Knight Alzheimer Disease Research Center, Washington University in St Louis, St Louis, Missouri, USA.
Förderung
- Lisa Dean Moseley Foundation
- NINDS NIH HHS
- U.S. Department of Defense
- NIA NIH HHS
- Rainwater Charitable Organization
- CURE program from Drexel University College of Medicine
- Alzheimer's Association
- National Institute on Aging
Zitieren
APA
Sun, X., Ramakrishnan, S., Ogbolu, V. C., Kanaan, N. M., Karch, C. M., Baas, P. W., & Qiang, L. (2026). Patient‐derived forebrain cortical organoids reveal biphasic tau–MAP6–microtubule axis dysfunction in tauopathy. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71565
Vancouver
Sun X, Ramakrishnan S, Ogbolu VC, Kanaan NM, Karch CM, Baas PW, et al. Patient‐derived forebrain cortical organoids reveal biphasic tau–MAP6–microtubule axis dysfunction in tauopathy. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71565
BibTeX
@article{Sun2026,
author = {Sun, Xiaohuan and Ramakrishnan, Skandha and Ogbolu, Victor C and Kanaan, Nicholas M and Karch, Celeste M and Baas, Peter W and Qiang, Liang},
title = {Patient‐derived forebrain cortical organoids reveal biphasic tau–MAP6–microtubule axis dysfunction in tauopathy},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71565}
}
EUVIMED